Detalles de la búsqueda
1.
Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysis.
Haematologica
; 109(2): 604-616, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584290
2.
Isatuximab in combination with carfilzomib and dexamethasone in 1q21+ patients with relapsed/refractory multiple myeloma: Long-term outcomes in the Phase 3 IKEMA study.
Hematol Oncol
; 42(2): e3258, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402467
3.
Associations of baseline and longitudinal change in cerebellum volume with age-related changes in verbal learning and memory.
Neuroimage
; 272: 120048, 2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36958620
4.
Recognition Memory is Associated with Distinct Patterns of Regional Gray Matter Volumes in Young and Aged Monkeys.
Cereb Cortex
; 32(5): 933-948, 2022 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34448810
5.
Application and validation of an algorithmic classification of early impairment in cognitive performance.
Aging Ment Health
; 27(11): 2187-2192, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354067
6.
Associations between cognitive and brain volume changes in cognitively normal older adults.
Neuroimage
; 223: 117289, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32835822
7.
Hearing loss and cognitive function among Chinese older adults: the role of participation in leisure activities.
BMC Geriatr
; 20(1): 215, 2020 06 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32560691
8.
The association of a novel cognitive frailty index and physical functioning in older at-risk adults.
Aging Ment Health
; 24(1): 129-136, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30668137
9.
Discrimination of degrees of auditory performance from the digits-in-noise test based on hearing status.
Int J Audiol
; 59(12): 897-904, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32673129
10.
Associations Between Midlife (but Not Late-Life) Elevated Coronary Heart Disease Risk and Lower Cognitive Performance: Results From the Framingham Offspring Study.
Am J Epidemiol
; 188(12): 2175-2187, 2019 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31576397
11.
Combined neuropathological pathways account for age-related risk of dementia.
Ann Neurol
; 84(1): 10-22, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29944741
12.
Association of physical functioning of persons with dementia with caregiver burden and depression in dementia caregivers: an integrative data analysis.
Aging Ment Health
; 23(5): 587-594, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29469590
13.
Optimal metrics for identifying long term patterns of depression in older HIV-infected and HIV-uninfected men who have sex with men.
Aging Ment Health
; 23(4): 507-514, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29424569
14.
Apolipoprotein E ε4 allele effects on longitudinal cognitive trajectories are sex and age dependent.
Alzheimers Dement
; 15(12): 1558-1567, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31561966
15.
Late-Life Depressive Symptoms as Partial Mediators in the Associations between Subclinical Cardiovascular Disease with Onset of Mild Cognitive Impairment and Dementia.
Am J Geriatr Psychiatry
; 26(5): 559-568, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29254675
16.
Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus.
J Neurovirol
; 23(4): 558-567, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28429290
17.
Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults.
Orphanet J Rare Dis
; 18(1): 94, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098529
18.
Application and validation of an algorithmic classification of early impairment in cognitive performance.
medRxiv
; 2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36798178
19.
Sensory impairment and algorithmic classification of early cognitive impairment.
Alzheimers Dement (Amst)
; 15(2): e12400, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37063388
20.
Continued improvement in disease manifestations of acid sphingomyelinase deficiency for adults with up to 2 years of olipudase alfa treatment: open-label extension of the ASCEND trial.
Orphanet J Rare Dis
; 18(1): 378, 2023 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042851